Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robbin G. Cohen, MD
University of Southern California
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Providence Cancer Center
Mobile, Alabama, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Huntington Cancer Center at Huntington Hospital
Pasadena, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- University of Colorado Health Sciences Center - Denver
Denver, Colorado, United States
- Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Bayfront Medical Center
St. Petersburg, Florida, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States
- Cancer Institute at St. John'S Hospital
Springfield, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Jewish Hospital
Louisville, Kentucky, United States
- Hurley Medical Center
Flint, Michigan, United States
- Mclaren Regional Cancer Center
Flint, Michigan, United States
- William Beaumont Hospital - Royal Oak
Royal Oak, Michigan, United States
- Siteman Cancer Center
St Louis, Missouri, United States
- Creighton University School of Medicine
Omaha, Nebraska, United States
- Veterans Affairs Medical Center - Omaha
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Long Island Cancer Center at Stony Brook University Hospital
Stony Brook, New York, United States
- University Hospital at State University of New York - Upstate Medical University
Syracuse, New York, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Metrohealth'S Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Cancer Institute at Oregon Health and Science University
Portland, Oregon, United States
- Providence Cancer Center at Providence Portland Medical Center
Portland, Oregon, United States
- Westmoreland Regional Hospital
Greensburg, Pennsylvania, United States
- Jameson Memorial Hospital
New Castle, Pennsylvania, United States
- Abramson Cancer Center of the University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- Temple University Hospital
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 1999
- Primary completion
- 31 Oct 2011
- Completion
- 31 Oct 2011
- Last update posted
- 16 Feb 2017
- Registered enrollment
- 1,310
- Registry id
- NCT00003901
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.